{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-21-034304","form_type":"8-K","ticker":"TPB","cik":"0001290677","company_name":"Turning Point Brands, Inc.","filed_at":"2021-10-12T23:59:59+00:00","discovered_at":"2026-05-14T18:04:11.925941+00:00","generated_at":"2026-06-28T21:20:10.775431+00:00","sec_items":["8.01","9.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"FDA rescinds Marketing Denial Order on TPB vapor products; products remain under review","bullets":["On Oct 7, FDA rescinded its Sept 14 Marketing Denial Order for certain TPB vapor products, citing need for further review.","All proprietary vapor products (incl. Solace e-liquids) will continue marketing while PMTAs remain under FDA review.","TPB withdrew its petition for review and motion to stay filed with the 6th Circuit following the rescission.","CEO Larry Wexler expressed encouragement and reiterated commitment to evidence-based PMTA process."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-21-034304","json":"https://secwatch.observer/filing/0001140361-21-034304.json","markdown":"https://secwatch.observer/filing/0001140361-21-034304.md","text":"https://secwatch.observer/filing/0001140361-21-034304.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1290677/000114036121034304/0001140361-21-034304-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1290677/000114036121034304/brhc10029756_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T21:20:10.775431+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}